{"id":"NCT01253811","sponsor":"Novo Nordisk A/S","briefTitle":"Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency","officialTitle":"A Multi-Centre, Multinational, Open-Label, Single-Arm and Multiple Dosing Trial on Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency. Safety Extension Trial to F13CD-3760","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01","primaryCompletion":"2015-03","completion":"2015-03","firstPosted":"2010-12-03","resultsPosted":"2016-06-24","lastUpdate":"2016-06-24"},"enrollment":6,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Congenital Bleeding Disorder","Congenital FXIII Deficiency"],"interventions":[{"type":"DRUG","name":"catridecacog","otherNames":["recombinant factor XIII"]}],"arms":[{"label":"rFXIII 35 IU/kg","type":"EXPERIMENTAL"}],"summary":"This trial will be conducted in Asia, Europe and the United States of America (USA).\n\nThe aim of this clinical trial is to investigate long-term safety of rFXIII when administered for prevention of bleeding episodes in children aged between 1 and 6 years with congenital FXIII A-subunit deficiency. This trial is an extension to trial F13CD-3760 (mentorâ„¢4, NCT01230021). If applicable the trial will be extended up to maximum 3 years dependent on when recombinant factor XIII will be commercially available in subject's respective country for use in children of 1-6 years of age.","primaryOutcome":{"measure":"Number of Treatment Emergent (Serious and Non-serious) Adverse Events","timeFrame":"Week 0 to end of trial visit (week 173) for a minimum period of 52 weeks.","effectByArm":[{"arm":"rFXIII 35 IU/kg","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":7},"locations":{"siteCount":4,"countries":["United States","Israel","United Kingdom"]},"refs":{"pmids":["28581691"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":6},"commonTop":["Pyrexia","Diarrhoea","Upper respiratory tract infection","Contusion","Fall"]}}